Institutional investors purchased a net $416.0 thousand shares of OPXA during the quarter ended September 2015, and now own 5.16% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 4.5 Thousand shares of Opexa Therapeutics Inc